PASYLATION Trademark

Trademark Overview


On Wednesday, October 17, 2012, a trademark application was filed for PASYLATION with the United States Patent and Trademark Office. The USPTO has given the PASYLATION trademark a serial number of 79126686. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Monday, October 7, 2024. This trademark is owned by XL-protein GmbH. The PASYLATION trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Scientific and technological services and research, namely, scientific research, analysis, testing, in the fields of chemistry, genetics, biology, biotechnology and biochemistry; [ technical services, namely, computer diagnostic services in the field of DNA, RNA and protein expression, detection and analysis and respective design services, in particular in the fields of chemistry, genetics, biology, biotechnology and biochemistry; industrial analysis and research services in the field of medical, dental, forensic and scientific research; design and development of computer hardware and software; ] services of a chemical and biochemical laboratory; scientific research including conducting of scientific examinations; and preparation of scientific opinions; quality checking, namely, quality evaluation services for the medical and pharmaceutical industry; [ design and development of programs for data processing; ] consultancy for scientific, laboratory and research purposes in the field of ...

[ Chemicals and biochemicals for research and laboratory purposes excluding for medical or veterinary purposes, and for industrial and scientific purposes; [ unprocessed artificial resins, unprocessed plastics; ] chemical and biological preparations for medical research and medical and scientific purposes ]

[ Pharmaceutical and veterinary preparations and preparations for human medical purposes for use in treating growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; [ sanitary preparations for medical purposes; dietetic substances adapted for medical use, namely, nutritional supplements containing proteins, peptides, food for babies; preparations for destroying vermin; fungicides, herbicides; ] pharmaceutical and diagnostic preparations for medical [, dental and forensic ] purposes and for purposes of [ forensic medicine and ] laboratory medicine, namely, pharmaceutical and diagnostic preparations for diagnosis, prevention, treatment or cure of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; testing reagents in kit form for medi...
pasylation

General Information


Serial Number79126686
Word MarkPASYLATION
Filing DateWednesday, October 17, 2012
Status706 - SECTION 71 ACCEPTED
Status DateMonday, October 7, 2024
Registration Number4483086
Registration DateTuesday, February 18, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2013

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesScientific and technological services and research, namely, scientific research, analysis, testing, in the fields of chemistry, genetics, biology, biotechnology and biochemistry; [ technical services, namely, computer diagnostic services in the field of DNA, RNA and protein expression, detection and analysis and respective design services, in particular in the fields of chemistry, genetics, biology, biotechnology and biochemistry; industrial analysis and research services in the field of medical, dental, forensic and scientific research; design and development of computer hardware and software; ] services of a chemical and biochemical laboratory; scientific research including conducting of scientific examinations; and preparation of scientific opinions; quality checking, namely, quality evaluation services for the medical and pharmaceutical industry; [ design and development of programs for data processing; ] consultancy for scientific, laboratory and research purposes in the field of chemistry, genetics, biology, biotechnology and biochemistry; [ scientific services of a technical measuring and test laboratory; ] technological consulting services pertaining to scientific and industrial scientific research in the fields of generation, technical processing and technical analysis of biomaterials and medically relevant data
Goods and Services[ Chemicals and biochemicals for research and laboratory purposes excluding for medical or veterinary purposes, and for industrial and scientific purposes; [ unprocessed artificial resins, unprocessed plastics; ] chemical and biological preparations for medical research and medical and scientific purposes ]
Translation of Words in MarkThe wording "PASYLATION" has no meaning in a foreign language.
Goods and Services[ Pharmaceutical and veterinary preparations and preparations for human medical purposes for use in treating growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; [ sanitary preparations for medical purposes; dietetic substances adapted for medical use, namely, nutritional supplements containing proteins, peptides, food for babies; preparations for destroying vermin; fungicides, herbicides; ] pharmaceutical and diagnostic preparations for medical [, dental and forensic ] purposes and for purposes of [ forensic medicine and ] laboratory medicine, namely, pharmaceutical and diagnostic preparations for diagnosis, prevention, treatment or cure of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; testing reagents in kit form for medical, [ dental and forensic ] purposes and for purposes of [ forensic medicine and ] laboratory medicine, namely, medical [ and forensic ] diagnostic reagents and assays for testing of body tissues and body fluids; chemical and biotechnological preparations for medical and diagnostic purposes, namely, reagents and solvents for sample preparation, modification and manipulation of cells and for performing of marking, separation, isolation, purification, amplification and/or analytical methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes included in this class; medicaments for preventive, curative and palliative purposes for preventing, treating or curing of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; medical biomarkers, in particular for preventative, diagnostic, prognostic or predictive purposes, namely, polypeptide sequences; [ medical preparations, namely, kits for laboratory medicine in particular for preventive, diagnostic, prognostic or predictive purposes, namely, diagnostic kits consisting primarily of proteins, buffers, and reagents for use in detecting growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; ] biomolecules for medical purposes, namely, proteins, peptides and small molecule drugs with conjugated polypeptide sequences for binding of active substances; medical preparations for analytical purposes, namely, reagents for detecting growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; preparations for health care, namely, for diagnosis, prevention, treatment, or cure of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases ]
Pseudo MarkPAS YLATION

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeG - NOT AVAILABLE
Class Status DateTuesday, December 29, 2020
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeG - NOT AVAILABLE
Class Status DateTuesday, December 29, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 18, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameXL-protein GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressFreising 85354
DE

Party NameXL-protein GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
Address85354 Freising
DE

Party NameXL-protein GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFreising 85354
DE

Trademark Events


Event DateEvent Description
Friday, March 15, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, March 18, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 18, 2013ASSIGNED TO EXAMINER
Friday, March 22, 2013APPLICATION FILING RECEIPT MAILED
Wednesday, March 27, 2013NON-FINAL ACTION WRITTEN
Thursday, March 28, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, March 28, 2013REFUSAL PROCESSED BY MPU
Thursday, March 28, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, April 23, 2013REFUSAL PROCESSED BY IB
Thursday, September 19, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 19, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 19, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 20, 2013ASSIGNED TO LIE
Thursday, September 26, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 26, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 29, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 30, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 13, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 13, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 13, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, December 2, 2013NOTIFICATION PROCESSED BY IB
Tuesday, December 3, 2013PUBLISHED FOR OPPOSITION
Tuesday, December 3, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 18, 2014REGISTERED-PRINCIPAL REGISTER
Sunday, May 18, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, June 6, 2014FINAL DISPOSITION PROCESSED
Friday, June 6, 2014FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 27, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, July 13, 2017NEW REPRESENTATIVE AT IB RECEIVED
Monday, February 18, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, February 18, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 18, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 18, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 18, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 18, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 18, 2020TEAS SECTION 71 & 15 RECEIVED
Monday, April 6, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, May 12, 2020POST REGISTRATION ACTION MAILED - SEC. 71 & 15
Friday, October 2, 2020TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Sunday, December 27, 2020PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Tuesday, December 29, 2020REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Tuesday, December 29, 2020NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Thursday, December 31, 2020INVALIDATION PROCESSED
Friday, January 1, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Saturday, February 13, 2021PARTIAL INVALIDATION PROCESSED BY THE IB
Sunday, August 29, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, September 9, 2021INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Saturday, July 2, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, November 4, 2022INTERNATIONAL REGISTRATION RENEWED
Saturday, February 18, 2023COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Monday, February 12, 2024TEAS SECTION 71 RECEIVED
Monday, October 7, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, October 7, 2024REGISTERED-SEC.71 ACCEPTED
Monday, October 7, 2024NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sunday, June 8, 2025PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, October 30, 2025INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE